肾盂成形术前是否应行排尿性膀胱尿道造影
回顾性分析2000至2017年270例单侧肾盂输尿管连接部梗阻行肾盂成形术患儿,其中24例(8.9%)合并膀胱输尿管反流。发热性尿路感染、肾盂前后径>28.8 mm及肾实质厚度<3.95 mm是合并膀胱输尿管反流的预测因素,作者认为术前排尿性膀胱尿道造影可限于具有上述特征的患儿。
要点
- 单侧肾盂输尿管连接部梗阻行肾盂成形术患儿中约1/11合并膀胱输尿管反流。
- 合并膀胱输尿管反流者中75%需内镜下输尿管口注射或输尿管膀胱再植术等干预。
- 发热性尿路感染、肾盂前后径>28.8 mm、肾实质厚度<3.95 mm提示合并膀胱输尿管反流。
核心结论
- 单侧肾盂输尿管连接部梗阻行肾盂成形术患儿中约每11例有1例合并膀胱输尿管反流,其中75%需针对膀胱输尿管反流行外科干预。
- 作者认为术前排尿性膀胱尿道造影可限于表现为发热性尿路感染、术前超声示肾盂前后径较大及肾实质厚度较薄的患儿。
研究设计与样本
- 回顾性分析2000至2017年间381例接受单侧肾盂成形术的患儿资料。
- 共270例资料完整且随访≥5年的患儿纳入研究,分为合并膀胱输尿管反流组(I组,n=24,8.9%)和无膀胱输尿管反流组(II组,n=246,91.1%)。
主要发现
- 270例患儿中男205例(75.9%),中位年龄4个月(2-98),197例(72.9%)有产前肾积水,中位随访11年(5-22)。
- 24例合并膀胱输尿管反流患儿中,II级6例(25%),III-V级18例(75%);同侧12例(50%)、对侧3例(12.5%)、双侧9例(37.5%)。
- 中位随访137个月期间,6例(25%)膀胱输尿管反流自行缓解,15例(62.5%)行内镜下输尿管口注射,3例(12.5%)行输尿管膀胱再植术。
- I组术前肾盂前后径为35.5(IQR 27.6-36.0),II组为26.5(IQR 25.0-35.0),I组显著较高(P=.004)。
- I组术前肾实质厚度为3.7(IQR 3.4-6.4),II组为5.8(IQR 4.4-6.1),I组显著较低(P=.026)。
关键数值与推荐
- 合并膀胱输尿管反流的预测因素:发热性尿路感染(OR 2.769,P=.048)。
- 合并膀胱输尿管反流的预测因素:肾实质厚度<3.95 mm(OR 1.367,P=.043)。
- 合并膀胱输尿管反流的预测因素:肾盂前后径>28.8 mm(OR 1.035,P=.001)。
临床怎么用
- 作者认为术前排尿性膀胱尿道造影可限于表现为发热性尿路感染、术前超声示肾盂前后径较大及肾实质厚度较薄的患儿。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the incidence of concomitant vesicoureteral reflux (VUR) in unilateral cases of ureteropelvic junction obstruction (UPJO) and to identify factors that predict VUR. METHODS: Files of 381 pediatric patients who underwent unilateral pyeloplasty between 2000 and 2017 were retrospectively reviewed. A total of 270 patients with available data and ≥5 years of follow-up were eligible for this study. Demographic parameters, preoperative hydronephrosis grade, renal pelvis anteroposterior diameter (APD), renal parenchymal thickness (PT), split renal functions on MAG-3 scan and VUR status were noted. The patients were divided into two groups: those with concomitant VUR (group I, n: 24, 8.9%) and those without VUR (group II, n: 246, 91.1%). RESULTS: Among 270 patients (205 boys, 75.9%) with a median age of 4 months (2-98), 197 (72.9%) had antenatal hydronephrosis. Median follow-up was 11 years (5-22). Among 24 patients with concurrent VUR, 6 (25%) had grade II VUR, whereas grade III-V VUR was detected in 18 (75%). Of these, 12 (50%) had ipsilateral VUR, 3 (12.5%) had contralateral, and 9 (37.5%) had bilateral VUR. In a median 137-month follow-up, spontaneous VUR resolution was observed in 6 (25%) patients, whereas 15 (62.5%) patients underwent endoscopic subureteral injection and 3 (12.5%) patients ureteroneocystostomy, respectively. Preoperative APD [35.5, (Inter Quantile Range) IQR (27.6-36.0) vs 26.5 IQR (25.0-35.0), P = .004] were significantly higher in group I, whereas group I had significantly lower PT [3.7, IQR (3.4-6.4) vs 5.8 IQR (4.4-6.1), P = .026]. Predictive factors for concomitant VUR were presentation with febrile UTI (odds ratio (OR): 2.769, P = .048), PT <3.95 mm (OR: 1.367, P = .043), and APD >28.8 mm (OR: 1.035, P = .001). CONCLUSION: Our results indicated that concomitant VUR and UPJO might be detected in 1 out of every 11 patients undergoing pyeloplasty, while some type of surgical intervention for VUR was required in 75% of these patients. Thus, voiding cystourethrogram prior to pyeloplasty may be limited in those presenting with febrile urinary tract infection, having higher APD and lower PT on preoperative urinary ultrasonography.
引用
- Selvi I, Dönmez Mİ, Değirmenci E, et al. Voiding Cystourethrogram Before Pyeloplasty: To Do or Not To Do? Urology. 2023. PMID: 37866651. doi:10.1016/j.urology.2023.10.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。